{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:23:39Z","timestamp":1792193019340,"version":"4.4.0"},"publisher-location":"Cham","reference-count":147,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031384363","type":"print"},{"value":"9783031384370","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/164_2022_625","type":"book-chapter","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T02:02:58Z","timestamp":1672624978000},"page":"227-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["CACNA1A-Related Channelopathies: Clinical Manifestations and Treatment Options"],"prefix":"10.1007","author":[{"given":"Elisabetta","family":"Indelicato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Boesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"625_CR1","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/s41431-021-00919-5","volume":"29","author":"A Arteche-Lopez","year":"2021","unstructured":"Arteche-Lopez A et al (2021) Biallelic variants in genes previously associated with dominant inheritance: CACNA1A, RET and SLC20A2. Eur J Hum Genet 29:1520\u20131526","journal-title":"Eur J Hum Genet"},{"key":"625_CR2","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1468-1331.2007.01900.x","volume":"14","author":"V Artto","year":"2007","unstructured":"Artto V et al (2007) Treatment of hemiplegic migraine with triptans. Eur J Neurol 14:1053\u20131056","journal-title":"Eur J Neurol"},{"key":"625_CR3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410310205","volume":"31","author":"PG Bain","year":"1992","unstructured":"Bain PG et al (1992) Familial periodic cerebellar ataxia: a problem of cerebellar intracellular pH homeostasis. Ann Neurol 31:147\u2013154","journal-title":"Ann Neurol"},{"key":"625_CR4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1212\/WNL.53.1.38","volume":"53","author":"S Battistini","year":"1999","unstructured":"Battistini S et al (1999) A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53:38\u201343","journal-title":"Neurology"},{"key":"625_CR5","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1089\/scd.2017.0085","volume":"26","author":"C Bavassano","year":"2017","unstructured":"Bavassano C et al (2017) Bicistronic CACNA1A gene expression in neurons derived from spinocerebellar ataxia type 6 patient-induced pluripotent stem cells. Stem Cells Dev 26:1612\u20131625","journal-title":"Stem Cells Dev"},{"key":"625_CR6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000079546","volume":"52","author":"K Beauvais","year":"2004","unstructured":"Beauvais K et al (2004) New CACNA1A gene mutation in a case of familial hemiplegic migraine with status epilepticus. Eur Neurol 52:58\u201361","journal-title":"Eur Neurol"},{"key":"625_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-444-64189-2.00006-8","volume":"155","author":"E Bertini","year":"2018","unstructured":"Bertini E, Zanni G, Boltshauser E (2018) Nonprogressive congenital ataxias. Handb Clin Neurol 155:91\u2013103","journal-title":"Handb Clin Neurol"},{"key":"625_CR8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10194-008-0067-1","volume":"9","author":"R Bhatia","year":"2008","unstructured":"Bhatia R et al (2008) Sporadic hemiplegic migraine: report of a case with clinical and radiological features. J Headache Pain 9:385\u2013388","journal-title":"J Headache Pain"},{"key":"625_CR9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1177\/0883073809351316","volume":"25","author":"L Blumkin","year":"2010","unstructured":"Blumkin L et al (2010) Congenital ataxia, mental retardation, and dyskinesia associated with a novel CACNA1A mutation. J Child Neurol 25:892\u2013897","journal-title":"J Child Neurol"},{"key":"625_CR10","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.ejpn.2021.07.001","volume":"33","author":"A Brunklaus","year":"2021","unstructured":"Brunklaus A (2021) Advances in genotype-phenotype associations for CACNA1A-related epilepsies. Eur J Paediatr Neurol 33:A2","journal-title":"Eur J Paediatr Neurol"},{"key":"625_CR11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1526-4610.2011.02014.x","volume":"51","author":"O Carreno","year":"2011","unstructured":"Carreno O et al (2011) Acute striatal necrosis in hemiplegic migraine with de novo CACNA1A mutation. Headache 51:1542\u20131546","journal-title":"Headache"},{"key":"625_CR12","doi-asserted-by":"crossref","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"WA Catterall","year":"2011","unstructured":"Catterall WA (2011) Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3:a003947","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"625_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jocn.2007.01.013","volume":"15","author":"YC Chan","year":"2008","unstructured":"Chan YC et al (2008) Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation. J Clin Neurosci 15:891\u2013894","journal-title":"J Clin Neurosci"},{"key":"625_CR14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaapos.2021.04.016","volume":"25","author":"MY Chang","year":"2021","unstructured":"Chang MY et al (2021) Paroxysmal tonic upgaze (PTU) associated with CACNA1A mutation and gross motor delay. J AAPOS 25:353\u2013353.e1","journal-title":"J AAPOS"},{"key":"625_CR15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s10072-013-1298-8","volume":"34","author":"KD Choi","year":"2013","unstructured":"Choi KD et al (2013) Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2. Neurol Sci 34:1629\u20131632","journal-title":"Neurol Sci"},{"key":"625_CR16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1468-2982.2009.01958.x","volume":"30","author":"C Cleves","year":"2010","unstructured":"Cleves C et al (2010) Link between confusional migraine, hemiplegic migraine and episodic ataxia type 2: hypothesis, family genealogy, gene typing and classification. Cephalalgia 30:740\u2013743","journal-title":"Cephalalgia"},{"key":"625_CR17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/awx081","volume":"140","author":"M Coutelier","year":"2017","unstructured":"Coutelier M et al (2017) A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. Brain 140:1579\u20131594","journal-title":"Brain"},{"key":"625_CR18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1111\/j.1468-2982.2008.01645.x","volume":"28","author":"E Cuenca-Leon","year":"2008","unstructured":"Cuenca-Leon E et al (2008) Genetic analysis of 27 Spanish patients with hemiplegic migraine, basilar-type migraine and childhood periodic syndromes. Cephalalgia 28:1039\u20131047","journal-title":"Cephalalgia"},{"key":"625_CR19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2009.01.005","volume":"280","author":"E Cuenca-Leon","year":"2009","unstructured":"Cuenca-Leon E et al (2009) Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene. J Neurol Sci 280:10\u201314","journal-title":"J Neurol Sci"},{"key":"625_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.pediatrneurol.2005.08.033","volume":"34","author":"RP Curtain","year":"2006","unstructured":"Curtain RP et al (2006) Minor head trauma-induced sporadic hemiplegic migraine coma. Pediatr Neurol 34:329\u2013332","journal-title":"Pediatr Neurol"},{"key":"625_CR21","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/ejhg.2015.21","volume":"23","author":"L Damaj","year":"2015","unstructured":"Damaj L et al (2015) CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur J Hum Genet 23:1505\u20131512","journal-title":"Eur J Hum Genet"},{"key":"625_CR22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/dmcn.13939","volume":"60","author":"A Danielsson","year":"2018","unstructured":"Danielsson A et al (2018) Benign paroxysmal torticollis of infancy does not lead to neurological sequelae. Dev Med Child Neurol 60:1251\u20131255","journal-title":"Dev Med Child Neurol"},{"key":"625_CR23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1468-2982.2008.01596.x","volume":"28","author":"B de Vries","year":"2008","unstructured":"de Vries B et al (2008) CACNA1A mutation linking hemiplegic migraine and alternating hemiplegia of childhood. Cephalalgia 28:887\u2013891","journal-title":"Cephalalgia"},{"key":"625_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00439-009-0684-z","volume":"126","author":"B de Vries","year":"2009","unstructured":"de Vries B et al (2009) Molecular genetics of migraine. Hum Genet 126:115\u2013132","journal-title":"Hum Genet"},{"key":"625_CR25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/j.1468-2982.2009.01884.x","volume":"29","author":"S Debiais","year":"2009","unstructured":"Debiais S et al (2009) The FHM1 mutation S218L: a severe clinical phenotype? A case report and review of the literature. Cephalalgia 29:1337\u20131339","journal-title":"Cephalalgia"},{"key":"625_CR26","unstructured":"(2012) Diuretics. In: LiverTox: clinical and research information on drug-induced liver injury, Bethesda"},{"key":"625_CR27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cell.2013.05.059","volume":"154","author":"X Du","year":"2013","unstructured":"Du X et al (2013) Second cistron in CACNA1A gene encodes a transcription factor mediating cerebellar development and SCA6. Cell 154:118\u2013133","journal-title":"Cell"},{"key":"625_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.seizure.2016.12.020","volume":"45","author":"X Du","year":"2017","unstructured":"Du X et al (2017) Dramatic response to pyridoxine in a girl with absence epilepsy with ataxia caused by a de novo CACNA1A mutation. Seizure 45:189\u2013191","journal-title":"Seizure"},{"key":"625_CR29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.neuron.2019.02.036","volume":"102","author":"X Du","year":"2019","unstructured":"Du X et al (2019) alpha1ACT is essential for survival and early cerebellar programming in a critical neonatal window. Neuron 102:770\u2013785.e7","journal-title":"Neuron"},{"key":"625_CR30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200107053450103","volume":"345","author":"A Ducros","year":"2001","unstructured":"Ducros A et al (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345:17\u201324","journal-title":"N Engl J Med"},{"key":"625_CR31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-2007-973493","volume":"30","author":"B Echenne","year":"1999","unstructured":"Echenne B et al (1999) Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics 30:214\u2013217","journal-title":"Neuropediatrics"},{"key":"625_CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/ern.12.13","volume":"12","author":"K Eikermann-Haerter","year":"2012","unstructured":"Eikermann-Haerter K, Can A, Ayata C (2012) Pharmacological targeting of spreading depression in migraine. Expert Rev Neurother 12:297\u2013306","journal-title":"Expert Rev Neurother"},{"key":"625_CR33","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajhg.2016.06.003","volume":"99","author":"KC Epi","year":"2016","unstructured":"Epi KC (2016) De novo mutations in SLC1A2 and CACNA1A are important causes of epileptic encephalopathies. Am J Hum Genet 99:287\u2013298","journal-title":"Am J Hum Genet"},{"key":"625_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","volume":"501","author":"KC Epi","year":"2013","unstructured":"Epi KC et al (2013) De novo mutations in epileptic encephalopathies. Nature 501:217\u2013221","journal-title":"Nature"},{"issue":"Pt 3","key":"625_CR35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/brain\/108.3.555-a","volume":"108","author":"RB Fitzsimons","year":"1985","unstructured":"Fitzsimons RB, Wolfenden WH (1985) Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia. Brain 108(Pt 3):555\u2013577","journal-title":"Brain"},{"key":"625_CR36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1468-2982.2008.01540.x","volume":"28","author":"T Freilinger","year":"2008","unstructured":"Freilinger T et al (2008) Expansion of the phenotypic spectrum of the CACNA1A T666M mutation: a family with familial hemiplegic migraine type 1, cerebellar atrophy and mental retardation. Cephalalgia 28:403\u2013407","journal-title":"Cephalalgia"},{"key":"625_CR37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jns.2010.09.032","volume":"300","author":"T Freilinger","year":"2011","unstructured":"Freilinger T et al (2011) A novel mutation in CACNA1A associated with hemiplegic migraine, cerebellar dysfunction and late-onset cognitive decline. J Neurol Sci 300:160\u2013163","journal-title":"J Neurol Sci"},{"key":"625_CR38","doi-asserted-by":"crossref","first-page":"116909","DOI":"10.1016\/j.jns.2020.116909","volume":"415","author":"A Fuerte-Hortigon","year":"2020","unstructured":"Fuerte-Hortigon A et al (2020) Novel CACNA1A variant may cause cervical dystonia and cerebellar ataxia syndrome. J Neurol Sci 415:116909","journal-title":"J Neurol Sci"},{"key":"625_CR39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.49.5.1247","volume":"49","author":"DH Geschwind","year":"1997","unstructured":"Geschwind DH et al (1997) Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations. Neurology 49:1247\u20131251","journal-title":"Neurology"},{"key":"625_CR40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fncel.2015.00036","volume":"9","author":"P Giunti","year":"2015","unstructured":"Giunti P et al (2015) Molecular mechanism of spinocerebellar ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation. Front Cell Neurosci 9:36","journal-title":"Front Cell Neurosci"},{"key":"625_CR41","doi-asserted-by":"crossref","unstructured":"Gonzalez-Mingot C, Lopez-Ortega R, Brieva-Ruiz L (2022) The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2. Neurol Sci:1\u20133","DOI":"10.1007\/s10072-022-06144-2"},{"key":"625_CR42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/pgmj.2004.022012","volume":"81","author":"TD Graves","year":"2005","unstructured":"Graves TD, Hanna MG (2005) Neurological channelopathies. Postgrad Med J 81:20\u201332","journal-title":"Postgrad Med J"},{"key":"625_CR43","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1212\/WNL.28.12.1259","volume":"28","author":"RC Griggs","year":"1978","unstructured":"Griggs RC et al (1978) Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 28:1259\u20131264","journal-title":"Neurology"},{"key":"625_CR44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pediatrneurol.2008.07.030","volume":"39","author":"AA Guerin","year":"2008","unstructured":"Guerin AA et al (2008) Stepwise developmental regression associated with novel CACNA1A mutation. Pediatr Neurol 39:363\u2013364","journal-title":"Pediatr Neurol"},{"key":"625_CR45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejpn.2020.10.004","volume":"30","author":"T Gur-Hartman","year":"2020","unstructured":"Gur-Hartman T, Berkowitz O, Yosovich K et al (2020) Clinical phenotypes of infantile onset CACNA1A-related disorder. Eur J Neurol Paedriatr Neurol 30:144\u2013154","journal-title":"Eur J Neurol Paedriatr Neurol"},{"key":"625_CR46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1468-2982.1995.1506477.x","volume":"15","author":"J Haan","year":"1995","unstructured":"Haan J et al (1995) Is familial hemiplegic migraine a hereditary form of basilar migraine? Cephalalgia 15:477\u2013481","journal-title":"Cephalalgia"},{"key":"625_CR47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache, S","year":"2013","unstructured":"Headache Classification Committee of the International Headache, S (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"625_CR48","doi-asserted-by":"crossref","first-page":"e56362","DOI":"10.1371\/journal.pone.0056362","volume":"8","author":"Y Hu","year":"2013","unstructured":"Hu Y et al (2013) Identification of a novel nonsense mutation p.Tyr1957Ter of CACNA1A in a Chinese family with episodic ataxia 2. PLoS One 8:e56362","journal-title":"PLoS One"},{"key":"625_CR49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dmcn.14261","volume":"62","author":"V Humbertclaude","year":"2020","unstructured":"Humbertclaude V et al (2020) Cognitive impairment in children with CACNA1A mutations. Dev Med Child Neurol 62:330\u2013337","journal-title":"Dev Med Child Neurol"},{"key":"625_CR50","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1093\/brain\/awh301","volume":"127","author":"P Imbrici","year":"2004","unstructured":"Imbrici P et al (2004) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain 127:2682\u20132692","journal-title":"Brain"},{"key":"625_CR51","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1212\/01.wnl.0000176069.64200.28","volume":"65","author":"P Imbrici","year":"2005","unstructured":"Imbrici P et al (2005) Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 65:944\u2013946","journal-title":"Neurology"},{"key":"625_CR52","doi-asserted-by":"crossref","first-page":"639994","DOI":"10.3389\/fneur.2021.639994","volume":"12","author":"E Indelicato","year":"2021","unstructured":"Indelicato E, Boesch S (2021) From genotype to phenotype: expanding the clinical spectrum of CACNA1A variants in the era of next generation sequencing. Front Neurol 12:639994","journal-title":"Front Neurol"},{"issue":"6","key":"625_CR53","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0333102417715229","volume":"38","author":"E Indelicato","year":"2017","unstructured":"Indelicato E et al (2017) Ten years of follow-up in a large family with familial hemiplegic migraine type 1: clinical course and implications for treatment. Cephalalgia 38(6):1167\u20131176","journal-title":"Cephalalgia"},{"key":"625_CR54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/ene.13765","volume":"26","author":"E Indelicato","year":"2019","unstructured":"Indelicato E et al (2019) The neuropsychiatric phenotype in CACNA1A mutations: a retrospective single center study and review of the literature. Eur J Neurol 26:66\u2013e7","journal-title":"Eur J Neurol"},{"issue":"6","key":"625_CR55","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1007\/s00415-021-10878-y","volume":"269","author":"E Indelicato","year":"2021","unstructured":"Indelicato E et al (2021a) Instrumented gait analysis defines the walking signature of CACNA1A disorders. J Neurol 269(6):2941\u20132947","journal-title":"J Neurol"},{"issue":"7","key":"625_CR56","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00415-021-10415-x","volume":"268","author":"E Indelicato","year":"2021","unstructured":"Indelicato E, Unterberger I, Nachbauer W, Eigentler A, Amprosi M, Zeiner F, Haberlandt E, Kaml M, Boesch S (2021b) The electrophysiological footprint of CACNA1A disorders. J Neurol 268(7):2493\u20132505","journal-title":"J Neurol"},{"key":"625_CR57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00424-020-02396-z","volume":"472","author":"M Izquierdo-Serra","year":"2020","unstructured":"Izquierdo-Serra M, Fernandez-Fernandez JM, Serrano M (2020) Rare CACNA1A mutations leading to congenital ataxia. Pflugers Arch 472:791\u2013809","journal-title":"Pflugers Arch"},{"key":"625_CR58","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H et al (2015) Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 14:1101\u20131108","journal-title":"Lancet Neurol"},{"key":"625_CR59","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jnnp.65.4.565","volume":"65","author":"JC Jen","year":"1998","unstructured":"Jen JC et al (1998) Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 65:565\u2013568","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"625_CR60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1212\/01.WNL.0000101675.61074.50","volume":"62","author":"J Jen","year":"2004","unstructured":"Jen J, Kim GW, Baloh RW (2004) Clinical spectrum of episodic ataxia type 2. Neurology 62:17\u201322","journal-title":"Neurology"},{"key":"625_CR61","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/brain\/awm126","volume":"130","author":"JC Jen","year":"2007","unstructured":"Jen JC et al (2007) Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 130:2484\u20132493","journal-title":"Brain"},{"key":"625_CR62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0140-6736(01)05971-2","volume":"358","author":"A Jouvenceau","year":"2001","unstructured":"Jouvenceau A et al (2001) Human epilepsy associated with dysfunction of the brain P\/Q-type calcium channel. Lancet 358:801\u2013807","journal-title":"Lancet"},{"key":"625_CR63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000315145","volume":"64","author":"J Jung","year":"2010","unstructured":"Jung J et al (2010) Phenotypic variability of episodic ataxia type 2 mutations: a family study. Eur Neurol 64:114\u2013116","journal-title":"Eur Neurol"},{"key":"625_CR64","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/WNN.0b013e3181c3a8a6","volume":"23","author":"E Karner","year":"2010","unstructured":"Karner E et al (2010) Cognitive functions, emotional behavior, and quality of life in familial hemiplegic migraine. Cogn Behav Neurol 23:106\u2013111","journal-title":"Cogn Behav Neurol"},{"key":"625_CR65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/WNN.0b013e318259cb36","volume":"25","author":"E Karner","year":"2012","unstructured":"Karner E et al (2012) Long-term outcome of cognitive functions, emotional behavior, and quality of life in a family with familial hemiplegic migraine. Cogn Behav Neurol 25:85\u201392","journal-title":"Cogn Behav Neurol"},{"key":"625_CR66","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ene.13621","volume":"25","author":"N Karsan","year":"2018","unstructured":"Karsan N et al (2018) Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. Eur J Neurol 25:811\u2013817","journal-title":"Eur J Neurol"},{"key":"625_CR67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H et al (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55:139\u2013141","journal-title":"Neurology"},{"key":"625_CR68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpn.2014.10.005","volume":"19","author":"S Kinder","year":"2015","unstructured":"Kinder S et al (2015) Novel frameshift mutation in the CACNA1A gene causing a mixed phenotype of episodic ataxia and familiar hemiplegic migraine. Eur J Paediatr Neurol 19:72\u201374","journal-title":"Eur J Paediatr Neurol"},{"key":"625_CR69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/mdc3.12075","volume":"1","author":"S Kipfer","year":"2014","unstructured":"Kipfer S, Strupp M (2014) The clinical spectrum of autosomal-dominant episodic ataxias. Mov Disord Clin Pract 1:285\u2013290","journal-title":"Mov Disord Clin Pract"},{"key":"625_CR70","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1161\/STROKEAHA.110.600023","volume":"42","author":"E Knierim","year":"2011","unstructured":"Knierim E et al (2011) Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil. Stroke 42:e14\u2013e17","journal-title":"Stroke"},{"key":"625_CR71","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-0040-1721686","volume":"52","author":"PY Ko","year":"2021","unstructured":"Ko PY et al (2021) Two missense CACNA1A variants in a single family with variable neurobehavioral, cerebellar, epileptic, and oculomotor features. Neuropediatrics 52:186\u2013191","journal-title":"Neuropediatrics"},{"key":"625_CR72","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.1031","volume":"49","author":"EE Kors","year":"2001","unstructured":"Kors EE et al (2001) Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine. Ann Neurol 49:753\u2013760","journal-title":"Ann Neurol"},{"key":"625_CR73","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/01.WNL.0000138571.48593.FC","volume":"63","author":"EE Kors","year":"2004","unstructured":"Kors EE et al (2004) Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63:1136\u20131137","journal-title":"Neurology"},{"key":"625_CR74","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/jmg.2009.067967","volume":"46","author":"RW Labrum","year":"2009","unstructured":"Labrum RW et al (2009) Large scale calcium channel gene rearrangements in episodic ataxia and hemiplegic migraine: implications for diagnostic testing. J Med Genet 46:786\u2013791","journal-title":"J Med Genet"},{"key":"625_CR75","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejpn.2021.05.010","volume":"33","author":"M Le Roux","year":"2021","unstructured":"Le Roux M et al (2021) CACNA1A-associated epilepsy: electroclinical findings and treatment response on seizures in 18 patients. Eur J Paediatr Neurol 33:75\u201385","journal-title":"Eur J Paediatr Neurol"},{"key":"625_CR76","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s10072-013-1325-9","volume":"34","author":"C Liguori","year":"2013","unstructured":"Liguori C et al (2013) May a suspicious psychiatric disorder hide sporadic hemiplegic migraine? Genetic test as prompting factor for diagnosis. Neurol Sci 34:1845\u20131846","journal-title":"Neurol Sci"},{"key":"625_CR77","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1046\/j.1528-1157.2001.33600.x","volume":"42","author":"LL Lim","year":"2001","unstructured":"Lim LL et al (2001) Acetazolamide in women with catamenial epilepsy. Epilepsia 42:746\u2013749","journal-title":"Epilepsia"},{"key":"625_CR78","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2013.06.008","volume":"36","author":"D Lipscombe","year":"2013","unstructured":"Lipscombe D, Allen SE, Toro CP (2013) Control of neuronal voltage-gated calcium ion channels from RNA to protein. Trends Neurosci 36:598\u2013609","journal-title":"Trends Neurosci"},{"key":"625_CR79","doi-asserted-by":"crossref","first-page":"17819","DOI":"10.1073\/pnas.0707945104","volume":"104","author":"RR Llinas","year":"2007","unstructured":"Llinas RR et al (2007) Gamma-band deficiency and abnormal thalamocortical activity in P\/Q-type channel mutant mice. Proc Natl Acad Sci U S A 104:17819\u201317824","journal-title":"Proc Natl Acad Sci U S A"},{"key":"625_CR80","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/brain\/awy325","volume":"142","author":"ICM Loonen","year":"2019","unstructured":"Loonen ICM et al (2019) Brainstem spreading depolarization and cortical dynamics during fatal seizures in Cacna1a S218L mice. Brain 142:412\u2013425","journal-title":"Brain"},{"key":"625_CR81","doi-asserted-by":"crossref","first-page":"e1006905","DOI":"10.1371\/journal.pgen.1006905","volume":"13","author":"X Luo","year":"2017","unstructured":"Luo X et al (2017) Clinically severe CACNA1A alleles affect synaptic function and neurodegeneration differentially. PLoS Genet 13:e1006905","journal-title":"PLoS Genet"},{"key":"625_CR82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1469-8749.2009.03493.x","volume":"52","author":"TJ Malpas","year":"2010","unstructured":"Malpas TJ et al (2010) Sporadic hemiplegic migraine and delayed cerebral oedema after minor head trauma: a novel de novo CACNA1A gene mutation. Dev Med Child Neurol 52:103\u2013104","journal-title":"Dev Med Child Neurol"},{"key":"625_CR83","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jns.2010.01.010","volume":"291","author":"E Mantuano","year":"2010","unstructured":"Mantuano E et al (2010) Identification of novel and recurrent CACNA1A gene mutations in fifteen patients with episodic ataxia type 2. J Neurol Sci 291:30\u201336","journal-title":"J Neurol Sci"},{"key":"625_CR84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000127974","volume":"60","author":"S Marti","year":"2008","unstructured":"Marti S et al (2008) Progressive cerebellar ataxia with variable episodic symptoms\u2013phenotypic diversity of R1668W CACNA1A mutation. Eur Neurol 60:16\u201320","journal-title":"Eur Neurol"},{"issue":"5","key":"625_CR85","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/head.12804","volume":"56","author":"PG Mathew","year":"2016","unstructured":"Mathew PG et al (2016) A retrospective analysis of triptan and dhe use for basilar and hemiplegic migraine. Headache 56(5):841\u2013848","journal-title":"Headache"},{"key":"625_CR86","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/jnnp.74.5.688","volume":"74","author":"S Mechtcheriakov","year":"2003","unstructured":"Mechtcheriakov S et al (2003) Schizophrenia and episodic ataxia type 2. J Neurol Neurosurg Psychiatry 74:688\u2013689","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"625_CR87","doi-asserted-by":"crossref","first-page":"106398","DOI":"10.1016\/j.eplepsyres.2020.106398","volume":"166","author":"N Mitta","year":"2020","unstructured":"Mitta N et al (2020) Genotype-phenotype correlates of infantile-onset developmental & epileptic encephalopathy syndromes in South India: a single centre experience. Epilepsy Res 166:106398","journal-title":"Epilepsy Res"},{"key":"625_CR88","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1212\/CPJ.0000000000001017","volume":"11","author":"C Muth","year":"2021","unstructured":"Muth C et al (2021) Fampridine and acetazolamide in EA2 and related familial EA: a prospective randomized placebo-controlled trial. Neurol Clin Pract 11:e438\u2013e446","journal-title":"Neurol Clin Pract"},{"key":"625_CR89","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00415-014-7310-2","volume":"261","author":"W Nachbauer","year":"2014","unstructured":"Nachbauer W et al (2014) Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature. J Neurol 261:983\u2013991","journal-title":"J Neurol"},{"key":"625_CR90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12883-020-01704-5","volume":"20","author":"R Nardello","year":"2020","unstructured":"Nardello R et al (2020) Two distinct phenotypes, hemiplegic migraine and episodic ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurol 20:155","journal-title":"BMC Neurol"},{"key":"625_CR91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mds.870110312","volume":"11","author":"MY Neufeld","year":"1996","unstructured":"Neufeld MY et al (1996) The electroencephalogram in acetazolamide-responsive periodic ataxia. Mov Disord 11:283\u2013288","journal-title":"Mov Disord"},{"key":"625_CR92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/mds.28835","volume":"37","author":"YV Nikonishyna","year":"2022","unstructured":"Nikonishyna YV et al (2022) Novel CACNA1A variant p.Cys256Phe disrupts disulfide bonds and causes spinocerebellar ataxia. Mov Disord 37:401\u2013404","journal-title":"Mov Disord"},{"key":"625_CR93","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dmcn.14985","volume":"64","author":"X Niu","year":"2022","unstructured":"Niu X et al (2022) Genotype-phenotype correlation of CACNA1A variants in children with epilepsy. Dev Med Child Neurol 64:105\u2013111","journal-title":"Dev Med Child Neurol"},{"key":"625_CR94","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10048-013-0375-8","volume":"14","author":"C Ohba","year":"2013","unstructured":"Ohba C et al (2013) Diagnostic utility of whole exome sequencing in patients showing cerebellar and\/or vermis atrophy in childhood. Neurogenetics 14:225\u2013232","journal-title":"Neurogenetics"},{"key":"625_CR95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81373-2","volume":"87","author":"RA Ophoff","year":"1996","unstructured":"Ophoff RA et al (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543\u2013552","journal-title":"Cell"},{"key":"625_CR96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12311-018-0917-6","volume":"17","author":"PDH Pastor","year":"2018","unstructured":"Pastor PDH et al (2018) Targeting the CACNA1A IRES as a treatment for spinocerebellar ataxia type 6. Cerebellum 17:72\u201377","journal-title":"Cerebellum"},{"key":"625_CR97","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1469-8749.2011.04154.x","volume":"54","author":"B Peer Mohamed","year":"2012","unstructured":"Peer Mohamed B, Goadsby PJ, Prabhakar P (2012) Safety and efficacy of flunarizine in childhood migraine: 11 years\u2019 experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol 54:274\u2013277","journal-title":"Dev Med Child Neurol"},{"key":"625_CR98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11940-012-0208-3","volume":"15","author":"N Pelzer","year":"2013","unstructured":"Pelzer N et al (2013) Familial and sporadic hemiplegic migraine: diagnosis and treatment. Curr Treat Options Neurol 15:13\u201327","journal-title":"Curr Treat Options Neurol"},{"key":"625_CR99","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1212\/WNL.0000000000004966","volume":"90","author":"N Pelzer","year":"2018","unstructured":"Pelzer N et al (2018a) Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology 90:e575\u2013e582","journal-title":"Neurology"},{"key":"625_CR100","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0333102417723569","volume":"38","author":"N Pelzer","year":"2018","unstructured":"Pelzer N et al (2018b) Brain atrophy following hemiplegic migraine attacks. Cephalalgia 38:1199\u20131202","journal-title":"Cephalalgia"},{"key":"625_CR101","doi-asserted-by":"crossref","first-page":"e1003709","DOI":"10.1371\/journal.pgen.1003709","volume":"9","author":"S Petrovski","year":"2013","unstructured":"Petrovski S et al (2013) Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet 9:e1003709","journal-title":"PLoS Genet"},{"key":"625_CR102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejpn.2019.11.002","volume":"25","author":"A Quade","year":"2020","unstructured":"Quade A et al (2020) Paroxysmal tonic upgaze: a heterogeneous clinical condition responsive to carbonic anhydrase inhibition. Eur J Paediatr Neurol 25:181\u2013186","journal-title":"Eur J Paediatr Neurol"},{"key":"625_CR103","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1113\/jphysiol.2009.186437","volume":"588","author":"S Rajakulendran","year":"2010","unstructured":"Rajakulendran S et al (2010) Genetic and functional characterisation of the P\/Q calcium channel in episodic ataxia with epilepsy. J Physiol 588:1905\u20131913","journal-title":"J Physiol"},{"key":"625_CR104","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nrneurol.2011.228","volume":"8","author":"S Rajakulendran","year":"2012","unstructured":"Rajakulendran S, Kaski D, Hanna MG (2012) Neuronal P\/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol 8:86\u201396","journal-title":"Nat Rev Neurol"},{"key":"625_CR105","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ajmg.a.37678","volume":"170","author":"K Reinson","year":"2016","unstructured":"Reinson K et al (2016) Biallelic CACNA1A mutations cause early onset epileptic encephalopathy with progressive cerebral, cerebellar, and optic nerve atrophy. Am J Med Genet A 170:2173\u20132176","journal-title":"Am J Med Genet A"},{"key":"625_CR106","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10048-009-0208-y","volume":"11","author":"F Riant","year":"2010","unstructured":"Riant F et al (2010) Identification of CACNA1A large deletions in four patients with episodic ataxia. Neurogenetics 11:101\u2013106","journal-title":"Neurogenetics"},{"key":"625_CR107","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1212\/WNL.0000000000012947","volume":"98","author":"F Riant","year":"2022","unstructured":"Riant F et al (2022) Hemiplegic migraine associated with PRRT2 variations: a clinical and genetic study. Neurology 98:e51\u2013e61","journal-title":"Neurology"},{"key":"625_CR108","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp.2008.163402","volume":"81","author":"R Romaniello","year":"2010","unstructured":"Romaniello R et al (2010) A wide spectrum of clinical, neurophysiological and neuroradiological abnormalities in a family with a novel CACNA1A mutation. J Neurol Neurosurg Psychiatry 81:840\u2013843","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"625_CR109","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0883073808322338","volume":"24","author":"NP Rosman","year":"2009","unstructured":"Rosman NP et al (2009) The neurology of benign paroxysmal torticollis of infancy: report of 10 new cases and review of the literature. J Child Neurol 24:155\u2013160","journal-title":"J Child Neurol"},{"key":"625_CR110","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s00415-008-0982-8","volume":"255","author":"A Roubertie","year":"2008","unstructured":"Roubertie A et al (2008) Benign paroxysmal tonic upgaze, benign paroxysmal torticollis, episodic ataxia and CACNA1A mutation in a family. J Neurol 255:1600\u20131602","journal-title":"J Neurol"},{"key":"625_CR111","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russell","year":"2011","unstructured":"Russell MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10:457\u2013470","journal-title":"Lancet Neurol"},{"key":"625_CR112","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pediatrneurol.2013.04.011","volume":"49","author":"I Sanchez-Albisua","year":"2013","unstructured":"Sanchez-Albisua I et al (2013) Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. Pediatr Neurol 49:286\u2013288","journal-title":"Pediatr Neurol"},{"key":"625_CR113","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1531-8249(199908)46:2<256::AID-ANA17>3.0.CO;2-6","volume":"46","author":"D Sappey-Marinier","year":"1999","unstructured":"Sappey-Marinier D et al (1999) Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol 46:256\u2013259","journal-title":"Ann Neurol"},{"key":"625_CR114","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/jnnp.64.1.67","volume":"64","author":"L Schols","year":"1998","unstructured":"Schols L et al (1998) Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry 64:67\u201373","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"625_CR115","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneur.62.2.314","volume":"62","author":"SD Spacey","year":"2005","unstructured":"Spacey SD et al (2005) Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 62:314\u2013316","journal-title":"Arch Neurol"},{"key":"625_CR116","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000008039","volume":"41","author":"M Spranger","year":"1999","unstructured":"Spranger M et al (1999) Familial hemiplegic migraine with cerebellar ataxia and paroxysmal psychosis. Eur Neurol 41:150\u2013152","journal-title":"Eur Neurol"},{"key":"625_CR117","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1399-0004.2008.00996.x","volume":"74","author":"AH Stam","year":"2008","unstructured":"Stam AH et al (2008) CACNA1A R1347Q: a frequent recurrent mutation in hemiplegic migraine. Clin Genet 74:481\u2013485","journal-title":"Clin Genet"},{"key":"625_CR118","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/jnnp.2009.177279","volume":"80","author":"AH Stam","year":"2009","unstructured":"Stam AH et al (2009) Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation. J Neurol Neurosurg Psychiatry 80:1125\u20131129","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"625_CR119","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/0333102410375629","volume":"31","author":"AH Stam","year":"2011","unstructured":"Stam AH et al (2011) A long-term follow-up study of 18 patients with sporadic hemiplegic migraine. Cephalalgia 31:199\u2013205","journal-title":"Cephalalgia"},{"key":"625_CR120","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.3390\/ijms21113810","volume":"21","author":"C Stendel","year":"2020","unstructured":"Stendel C et al (2020) Association of a novel splice site mutation in P\/Q-type calcium channels with childhood epilepsy and late-onset slowly progressive non-episodic cerebellar ataxia. Int J Mol Sci 21:3810","journal-title":"Int J Mol Sci"},{"key":"625_CR121","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1212\/WNL.49.5.1243","volume":"49","author":"G Stevanin","year":"1997","unstructured":"Stevanin G et al (1997) Clinical and molecular features of spinocerebellar ataxia type 6. Neurology 49:1243\u20131246","journal-title":"Neurology"},{"key":"625_CR122","doi-asserted-by":"crossref","first-page":"634760","DOI":"10.3389\/fnsyn.2021.634760","volume":"13","author":"J Striessnig","year":"2020","unstructured":"Striessnig J (2020) Voltage-gated Ca2+-channel de novo missense mutations: gain or loss of function \u2013 implications for potential therapies. Front Synaptic Neurosci 13:634760","journal-title":"Front Synaptic Neurosci"},{"key":"625_CR123","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1212\/01.WNL.0000078893.41040.56","volume":"61","author":"M Strupp","year":"2003","unstructured":"Strupp M et al (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165\u2013170","journal-title":"Neurology"},{"key":"625_CR124","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1212\/01.WNL.0000125691.74109.53","volume":"62","author":"M Strupp","year":"2004","unstructured":"Strupp M et al (2004) Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62:1623\u20131625","journal-title":"Neurology"},{"key":"625_CR125","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/brain\/awh440","volume":"128","author":"M Strupp","year":"2005","unstructured":"Strupp M et al (2005) Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia\u2013a comment. Brain 128:E32. Author reply E33","journal-title":"Brain"},{"key":"625_CR126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nurt.2007.01.014","volume":"4","author":"M Strupp","year":"2007","unstructured":"Strupp M, Zwergal A, Brandt T (2007) Episodic ataxia type 2. Neurotherapeutics 4:267\u2013273","journal-title":"Neurotherapeutics"},{"key":"625_CR127","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.0b013e318225ab07","volume":"77","author":"M Strupp","year":"2011","unstructured":"Strupp M et al (2011) A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 77:269\u2013275","journal-title":"Neurology"},{"key":"625_CR128","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.10756","volume":"54","author":"SH Subramony","year":"2003","unstructured":"Subramony SH et al (2003) Novel CACNA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits. Ann Neurol 54:725\u2013731","journal-title":"Ann Neurol"},{"key":"625_CR129","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/dmcn.13033","volume":"58","author":"EM Tantsis","year":"2016","unstructured":"Tantsis EM et al (2016) Eye movement disorders are an early manifestation of CACNA1A mutations in children. Dev Med Child Neurol 58:639\u2013644","journal-title":"Dev Med Child Neurol"},{"key":"625_CR130","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.2169\/internalmedicine.53.0295","volume":"53","author":"Y Tashiro","year":"2014","unstructured":"Tashiro Y et al (2014) Repeated encephalopathy and hemicerebral atrophy in a patient with familial hemiplegic migraine type 1. Intern Med 53:2245\u20132250","journal-title":"Intern Med"},{"key":"625_CR131","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0333102413513182","volume":"34","author":"R Topakian","year":"2014","unstructured":"Topakian R et al (2014) Rare clinical findings in a patient with sporadic hemiplegic migraine: FDG-PET provides diminished brain metabolism at 10-year follow-up. Cephalalgia 34:392\u2013396","journal-title":"Cephalalgia"},{"key":"625_CR132","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1212\/WNL.55.7.1040","volume":"55","author":"K Vahedi","year":"2000","unstructured":"Vahedi K et al (2000) CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy. Neurology 55:1040\u20131042","journal-title":"Neurology"},{"key":"625_CR133","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/PL00007866","volume":"249","author":"K Vahedi","year":"2002","unstructured":"Vahedi K et al (2002) Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomised placebo-controlled trial. J Neurol 249:206\u2013211","journal-title":"J Neurol"},{"key":"625_CR134","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2146\/ajhp170279","volume":"75","author":"MA Van Berkel","year":"2018","unstructured":"Van Berkel MA, Elefritz JL (2018) Evaluating off-label uses of acetazolamide. Am J Health Syst Pharm 75:524\u2013531","journal-title":"Am J Health Syst Pharm"},{"key":"625_CR135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.21815","volume":"67","author":"AM van den Maagdenberg","year":"2010","unstructured":"van den Maagdenberg AM et al (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice. Ann Neurol 67:85\u201398","journal-title":"Ann Neurol"},{"key":"625_CR136","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1007\/s00415-021-10555-0","volume":"268","author":"L Verriello","year":"2021","unstructured":"Verriello L et al (2021) Epilepsy and episodic ataxia type 2: family study and review of the literature. J Neurol 268:4296\u20134302","journal-title":"J Neurol"},{"key":"625_CR137","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0887-8994(01)00371-X","volume":"26","author":"T Wada","year":"2002","unstructured":"Wada T et al (2002) Wide clinical variability in a family with a CACNA1A T666m mutation: hemiplegic migraine, coma, and progressive ataxia. Pediatr Neurol 26:47\u201350","journal-title":"Pediatr Neurol"},{"key":"625_CR138","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pediatrneurol.2015.10.014","volume":"55","author":"DL Weyhrauch","year":"2016","unstructured":"Weyhrauch DL et al (2016) Whole exome sequencing and heterologous cellular electrophysiology studies elucidate a novel loss-of-function mutation in the CACNA1A-encoded neuronal P\/Q-type calcium channel in a child with congenital hypotonia and developmental delay. Pediatr Neurol 55:46\u201351","journal-title":"Pediatr Neurol"},{"key":"625_CR139","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00415-008-0970-z","volume":"255","author":"I Yabe","year":"2008","unstructured":"Yabe I et al (2008) Downbeat positioning nystagmus is a common clinical feature despite variable phenotypes in an FHM1 family. J Neurol 255:1541\u20131544","journal-title":"J Neurol"},{"key":"625_CR140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pediatrneurol.2011.04.010","volume":"45","author":"S Yamazaki","year":"2011","unstructured":"Yamazaki S et al (2011) Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation. Pediatr Neurol 45:193\u2013196","journal-title":"Pediatr Neurol"},{"key":"625_CR141","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neulet.2010.10.064","volume":"487","author":"Q Ye","year":"2011","unstructured":"Ye Q et al (2011) Flunarizine blocks voltage-gated Na(+) and Ca(2+) currents in cultured rat cortical neurons: a possible locus of action in the prevention of migraine. Neurosci Lett 487:394\u2013399","journal-title":"Neurosci Lett"},{"key":"625_CR142","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1212\/WNL.57.9.1732","volume":"57","author":"W Yu","year":"2001","unstructured":"Yu W, Horowitz SH (2001) Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology 57:1732\u20131733","journal-title":"Neurology"},{"key":"625_CR143","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/01.WNL.0000042051.16284.70","volume":"60","author":"W Yu","year":"2003","unstructured":"Yu W, Horowitz SH (2003) Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 60:120\u2013121","journal-title":"Neurology"},{"key":"625_CR144","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","volume":"67","author":"GW Zamponi","year":"2015","unstructured":"Zamponi GW et al (2015) The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential. Pharmacol Rev 67:821\u2013870","journal-title":"Pharmacol Rev"},{"key":"625_CR145","doi-asserted-by":"crossref","first-page":"577544","DOI":"10.3389\/fped.2020.577544","volume":"8","author":"L Zhang","year":"2020","unstructured":"Zhang L et al (2020) CACNA1A gene variants in eight Chinese patients with a wide range of phenotypes. Front Pediatr 8:577544","journal-title":"Front Pediatr"},{"key":"625_CR146","doi-asserted-by":"crossref","first-page":"722105","DOI":"10.3389\/fped.2021.722105","volume":"9","author":"LP Zhang","year":"2021","unstructured":"Zhang LP, Jia Y, Wang YP (2021) Identification of two de novo variants of CACNA1A in pediatric Chinese patients with paroxysmal tonic upgaze. Front Pediatr 9:722105","journal-title":"Front Pediatr"},{"key":"625_CR147","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ng0197-62","volume":"15","author":"O Zhuchenko","year":"1997","unstructured":"Zhuchenko O et al (1997) Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 15:62\u201369","journal-title":"Nat Genet"}],"container-title":["Handbook of Experimental Pharmacology","Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2022_625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T18:43:01Z","timestamp":1690828981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2022_625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031384363","9783031384370"],"references-count":147,"URL":"https:\/\/doi.org\/10.1007\/164_2022_625","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"3 January 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}